67 results
8-K
EX-10.6
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
such inquiries nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives shall modify, amend or affect Buyer’s … . Absence of Litigation. There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self
8-K
EX-10.2
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
such inquiries nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives shall modify, amend or affect Buyer’s … , inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge
8-K
EX-10.4
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
to the public prior to or promptly following such disclosure to the Buyer. Neither such inquiries nor any other due diligence investigation conducted by Buyer … , proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending
8-K
EX-10.3
7c23i0e2oueesyh5
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.1
g35 lmbs1a
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
EX-10.4
nzkgy9bo
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.2
o085hk8x jqiag
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.4
fpnuf82c1g
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.2
xlqlbya60msx7v
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-3.2
g5h6deoc95
5 Oct 23
Index to Financial Statements
5:12pm